We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.82B
AUM Growth
-$17.3M
Cap. Flow
+$5.08M
Cap. Flow %
0.28%
Top 10 Hldgs %
24.3%
Holding
256
New
8
Increased
74
Reduced
146
Closed
13

Top Buys

Rank Stock Value
1
BIRK icon
Birkenstock
BIRK
+$19.8M
2
QDEL icon
QuidelOrtho
QDEL
+$15.6M
3
G icon
Genpact
G
+$11.2M
4
LRN icon
Stride
LRN
+$11.1M
5
SRAD icon
Sportradar
SRAD
+$8.21M

Top Sells

Rank Stock Value
1
TKO icon
TKO Group
TKO
+$21.2M
2
MEDP icon
Medpace
MEDP
+$16.4M
3
INSM icon
Insmed
INSM
+$13.7M
4
WNS
WNS Holdings
WNS
+$7.77M
5
ESTA icon
Establishment Labs
ESTA
+$6.56M

Sector Composition

Rank Sector Weight
1 Healthcare 35.36%
2 Technology 27.54%
3 Industrials 16.33%
4 Consumer Discretionary 7.8%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRC
201
Commerce.com Inc Series 1
CMRC
$176M
$912K 0.05%
221,367
-28,150
-11% -$130K
TDY icon
202
Teledyne Technologies
TDY
$32.1B
$894K 0.05%
1,751
-2
-0.1% -$1.05K
EXEL icon
203
Exelixis
EXEL
$13.3B
$883K 0.05%
20,152
-47
-0.2% -$1.94K
EBAY icon
204
eBay
EBAY
$47.5B
$809K 0.04%
9,287
-18
-0.2% -$1.56K
INSM icon
205
Insmed
INSM
$28.8B
$789K 0.04%
4,536
-75,131
-94% -$13.7M
BRK.A icon
206
Berkshire Hathaway Class A
BRK.A
$1.15T
$755K 0.04%
1
ABT icon
207
Abbott
ABT
$187B
$754K 0.04%
6,019
-10
-0.2% -$1.27K
SNWV
208
SANUWAVE Health Inc
SNWV
$49.9M
$751K 0.04%
25,156
-2,146
-8% -$68.8K
CR icon
209
Crane Co
CR
$12.7B
$652K 0.04%
3,535
-7
-0.2% -$1.3K
AAPL icon
210
Apple
AAPL
$4.47T
$648K 0.04%
2,385
JPM icon
211
JPMorgan Chase
JPM
$953B
$635K 0.03%
1,970
BTMD icon
212
Biote Corp
BTMD
$46.1M
$626K 0.03%
240,829
+13,805
+6% +$37.7K
KEX icon
213
Kirby Corp
KEX
$6.96B
$605K 0.03%
5,493
-12
-0.2% -$1.22K
IEX icon
214
IDEX
IEX
$17.3B
$594K 0.03%
3,338
-5
-0.1% -$854
TECH icon
215
Bio-Techne
TECH
$11.3B
$593K 0.03%
10,091
-12
-0.1% -$729
EW icon
216
Edwards Lifesciences
EW
$52.7B
$561K 0.03%
6,581
-11
-0.2% -$903
DENN
217
DELISTED
Denny's
DENN
$559K 0.03%
89,861
+5,940
+7% +$33.7K
CVX icon
218
Chevron
CVX
$378B
$542K 0.03%
3,557
XOM icon
219
ExxonMobil
XOM
$655B
$533K 0.03%
4,429
KNX icon
220
Knight Transportation
KNX
$11.3B
$501K 0.03%
9,581
-20
-0.2% -$937
TFX icon
221
Teleflex
TFX
$5.98B
$495K 0.03%
4,057
-206
-5% -$25K
BRKR icon
222
Bruker
BRKR
$8.5B
$483K 0.03%
10,256
-16
-0.2% -$676
J icon
223
Jacobs Solutions
J
$17B
$470K 0.03%
3,545
IFF icon
224
International Flavors & Fragrances
IFF
$21.5B
$468K 0.03%
+6,950
New +$450K
WMT icon
225
Walmart Inc
WMT
$883B
$431K 0.02%
3,873

Similar funds

Rice Hall James & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Rice Hall James & Associates held 256 positions worth $1.82B, down 0.95% from $1.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q4 2025 filing shows 8 new, 74 increased, 146 reduced and 13 closed positions. Its largest new stake was Birkenstock: 466,577 shares worth $19.1M. The largest sale was TKO Group, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q4 2025 buy was Birkenstock: 466,577 shares worth $19.1M.
  • Rice Hall James & Associates added most to QuidelOrtho in Q4 2025, an estimated $15.6M increase.
  • Rice Hall James & Associates's biggest Q4 2025 reduction was TKO Group, cutting an estimated $21.2M.
  • Rice Hall James & Associates fully exited WNS Holdings in Q4 2025, selling an estimated $7.77M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.82B portfolio in Q4 2025.
  • Rice Hall James & Associates opened 8 new positions and closed 13 in Q4 2025.
  • Rice Hall James & Associates's portfolio value fell 0.95% quarter-over-quarter to $1.82B.

Based on Rice Hall James & Associates's 13F filing for Q4 2025, filed 17 Feb 2026.